Atopic Dermatitis Significantly Raises Risk of Fibromyalgia, New Study Shows
Taiwan: Patients with atopic dermatitis (AD) face a markedly higher likelihood of developing fibromyalgia, a large Taiwanese cohort study published in the Indian Journal of Dermatology, Venereology and Leprology has suggested.
The nationwide analysis revealed that individuals with AD had more than a sevenfold greater risk of fibromyalgia compared with people without the skin condition. The risk was even more pronounced in those with moderate-to-severe AD and among younger patients, highlighting the need for early pain assessment and monitoring in this population.
The research was led by Dr. Chien-Peng Huang from the Department of Pathology, Tri-Service General Hospital, National Defense Medical Center in Taipei, Taiwan, alongside an international team of collaborators. Drawing on data from Taiwan’s National Health Insurance Research Database, the investigators aimed to clarify whether AD—an inflammatory skin disorder—predisposes patients to fibromyalgia, a chronic pain syndrome thought to share neuroimmune and inflammatory pathways with AD.
The team evaluated health records from 1995 to 2010, identifying 4,147 patients aged 10 years or older with atopic dermatitis but no prior psychiatric history. For comparison, they selected 41,470 age- and sex-matched individuals without AD. All participants were tracked until 2013. Using stratified Cox-regression models adjusted for potential confounders, the researchers assessed the incidence of fibromyalgia across age groups and disease severity.
Key Findings:
- Patients with atopic dermatitis (AD) had an adjusted hazard ratio (aHR) of 7.12 for developing fibromyalgia compared with controls.
- Moderate-to-severe AD was linked to a hazard ratio of 7.72 for fibromyalgia.
- Mild AD carried a hazard ratio of 6.97 for fibromyalgia.
- Participants younger than 20 years had the highest risk, with a hazard ratio of 13.59.
- Adults aged 20 to 59 years had a hazard ratio of 6.31.
- Individuals over 60 years still faced a significant risk, with a hazard ratio of 3.89.
The authors note that shared neuroinflammatory mechanisms may explain the link between these conditions. Chronic inflammation, immune dysregulation, mast cell activation, and genetic factors such as polymorphisms in T-helper cells and interferon-related genes have all been implicated. Vitamin D imbalances may further contribute to the interplay between AD and fibromyalgia.
While the findings are compelling, the researchers acknowledge several limitations. Fibromyalgia cases were identified using ICD-9-CM codes, which may underestimate true incidence, and the database lacked details on lifestyle factors, family history, or environmental exposures that could affect disease development. Despite these constraints, the study’s strength lies in its large sample size and physician-confirmed diagnoses.
The authors urge clinicians to remain alert to signs of fibromyalgia in patients with atopic dermatitis, particularly younger individuals and those with more severe skin disease. Early screening and timely management, they emphasize, could improve quality of life and long-term outcomes for this at-risk population.
Reference:
Huang CP, Huang JS, Tsai SJ, Su TP, Chen TJ, Bai YM, et al. Increased risk of fibromyalgia in patients with atopic dermatitis: A nationwide longitudinal study. Indian J Dermatol Venereol Leprol. doi: 10.25259/IJDVL_577_2025
Next Story